Edition:
United States

aTyr Pharma Inc (LIFE.O)

LIFE.O on Nasdaq

3.29USD
2:04pm EDT
Change (% chg)

$0.02 (+0.61%)
Prev Close
$3.27
Open
$3.32
Day's High
$3.42
Day's Low
$3.22
Volume
34,199
Avg. Vol
218,146
52-wk High
$13.26
52-wk Low
$2.48

Latest Key Developments (Source: Significant Developments)

Atyr Pharma Inc qtrly loss per share $0.65
Wednesday, 10 Aug 2016 04:05pm EDT 

Atyr Pharma Inc : Atyr Pharma announces second quarter 2016 operating results . Atyr Pharma Inc qtrly loss per share $0.65 .Currently expect that our cash, cash equivalents and investments will be sufficient to fund our anticipated operations into 2018..  Full Article

Atyr Pharma qtrly loss per share $0.68
Wednesday, 11 May 2016 04:25pm EDT 

Atyr Pharma Inc : Qtrly loss per share $0.68 .Atyr pharma announces first quarter 2016 operating results.  Full Article

aTyr Pharma, Inc Announces Change in Leadership
Monday, 13 Jul 2015 04:00pm EDT 

aTyr Pharma, Inc:Says resignation of President and Chief Operating Officer Frederic Chereau to pursue other opportunities, effective immediately.  Full Article

aTyr Pharma Inc closes initial public offering
Tuesday, 12 May 2015 05:17pm EDT 

aTyr Pharma Inc:Closes initial public offering of 6,164,000 shares of common stock at an initial public offering price of $14 per share.Says common stock is listed on NASDAQ global select market under ticker symbol LIFE.J.P. Morgan Securities LLC and Citigroup Global Markets Inc. acted as joint book-running managers for the offering. BMO Capital Markets Corp. acted as lead manager and William Blair & Company, L.L.C. acted as co-manager.  Full Article

aTyr Pharma Inc announces pricing of initial public offering
Wednesday, 6 May 2015 08:16pm EDT 

aTyr Pharma Inc:Says pricing of its initial public offering of 5,360,000 shares of its common stock at initial public offering price of $14.00 per share.Says that in addition, aTyr has granted underwriters 30-day option to purchase up to additional 804,000 shares of common stock from aTyr at initial public offering price, less underwriting discounts and commissions.Says aTyr's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under ticker symbol LIFE on May 7.Says closing of offering is expected to occur on or about May 12.J.P. Morgan Securities LLC and Citigroup Global Markets Inc. are acting as joint book-running managers for offering.BMO Capital Markets Corp. is acting as lead manager and William Blair & Company, L.L.C. is acting as co-manager.  Full Article

BRIEF-Atyr Pharma Inc qtrly loss per share $0.65

* Atyr Pharma announces second quarter 2016 operating results